The short version of synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-01-31 and is reviewed periodically as new material appears.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Japan's porcelain industry was well-established at the start of the Meiji era, but the mass-produced wares were not known for their elegance. During this era, technical and artistic innovations turned porcelain into one of the most internationally successful Japanese decorative art forms. The career of porcelain artist Makuzu Kōzan is an archetype for the trajectory of Meiji art. He was passionate about preserving traditional influences but adopted new technologies from the West. He was an entrepreneur as well as an artist, organizing a workshop with many artisans and actively promoting his work at international exhibitions, travelling extensively in Europe. As his career went on, he adopted more Western influences on his decoration, while his works shaped Western perceptions of Japanese design. Underglaze blue painting on porcelain was well-established in Japan, and the Kozan workshop transformed this practice, combining multiple underglaze colors on a single item and introducing more subtle graduations of color. Satsuma ware was a name originally given to pottery from Satsuma province, elaborately decorated with gilt and enamel. These wares were highly praised in the West. Seen in the West as distinctively Japanese, this style actually owed a lot to imported pigments and Western influences and had been created with export in mind. Workshops in many cities raced to produce this style to satisfy demand from Europe and America, often producing quickly and cheaply.
retinal + NAD+ + H2O → retinoic acid + NADH + H+ Retinoic acid is actively transported into the cell nucleus by CRABp2 where it regulates thousands of genes by binding directly to gene targets via retinoic acid receptors. In addition to retinol, retinal and retinoic acid, there are plant-, fungi- or bacteria-sourced carotenoids which can be metabolized to retinol, and are thus vitamin A vitamers. There are also what are referred to as 2nd, 3rd and 4th generation retinoids which are not considered vitamin A vitamers because they cannot be converted to retinol, retinal or all-trans-retinoic acid. Some are prescription drugs, oral or topical, for various indications. Examples are etretinate, acitretin, adapalene, bexarotene, tazarotene and trifarotene.
=== Extended market indices === Russell 3000 Index: The Russell 3000 Index measures the performance of the largest 3,000 U.S. companies representing approximately 98% of the investable U.S. equity market.
==== MeSH D06.472.040 – adrenal cortex hormones ==== MeSH D06.472.040.502 – 17-ketosteroids MeSH D06.472.040.502.112 – androstenedione MeSH D06.472.040.502.195 – androsterone MeSH D06.472.040.502.497 – estrone MeSH D06.472.040.502.583 – etiocholanolone MeSH D06.472.040.502.620 – dehydroepiandrosterone MeSH D06.472.040.502.620.300 – dehydroepiandrosterone sulfate MeSH D06.472.040.585 – hydroxycorticosteroids MeSH D06.472.040.585.353 – 11-hydroxycorticosteroids MeSH D06.472.040.585.353.118 – aldosterone MeSH D06.472.040.585.353.237 – corticosterone MeSH D06.472.040.585.353.476 – hydrocortisone MeSH D06.472.040.585.353.500 – 18-hydroxycorticosterone MeSH D06.472.040.585.353.825 – tetrahydrocortisol MeSH D06.472.040.585.478 – 17-hydroxycorticosteroids MeSH D06.472.040.585.478.195 – cortisone MeSH D06.472.040.585.478.225 – cortodoxone MeSH D06.472.040.585.478.392 – hydrocortisone MeSH D06.472.040.585.478.782 – tetrahydrocortisol MeSH D06.472.040.585.478.865 – tetrahydrocortisone MeSH D06.472.040.585.611 – desoxycorticosterone MeSH D06.472.040.585.611.400 – 18-hydroxydesoxycorticosterone MeSH D06.472.040.585.745 – pregnenolone MeSH D06.472.040.585.745.500 – 17-alpha-hydroxypregnenolone
Amphetamine – systematic reviews and meta-analyses report that low-dose amphetamine may improve cognitive functions (e.g. inhibitory control, episodic memory, working memory, and aspects of attention) in healthy people and individuals with ADHD. A 2014 systematic review noted that low doses of amphetamine may also improve memory consolidation, in turn leading to improved recall of information in non-ADHD youth. It may also improve task salience (motivation to perform a task) and performance on tedious tasks that require a high degree of effort. Caffeine – a meta-analysis found a general increase in alertness and attention after consuming caffeine. Eugeroics (armodafinil and modafinil) – classified as "wakefulness-promoting agents"; modafinil may increase alertness, particularly in sleep-deprived individuals, and may improve reasoning and problem solving in non-ADHD youth. In a systematic review of small, preliminary studies where the effects of modafinil were examined, when simple psychometric assessments were considered, modafinil intake enhanced executive function. Modafinil does not seem to improve mood or motivation in sleep-deprived or non-sleep-deprived individuals. Methylphenidate – a benzylpiperidine derivative that may improve working memory, episodic memory, and inhibitory control; aspects of attention; and planning latency in healthy people. It also may improve task salience and performance on tedious tasks. At above optimal doses, methylphenidate has off–target effects that decrease learning.
Sources: en.wikipedia.org
=== Food safety === In 2003, the Codex Alimentarius removed any upper dose limit for food irradiation as well as clearances for specific foods, declaring that all are safe to irradiate. Countries such as Pakistan and Brazil have adopted the Codex without any reservation or restriction. Standards that describe calibration and operation for radiation dosimetry, as well as procedures to relate the measured dose to the effects achieved and to report and document such results, are maintained by the American Society for Testing and Materials (ASTM international) and are also available as ISO/ASTM standards. All of the rules involved in processing food are applied to all foods before they are irradiated.
==== Piggybacking ==== Some people find good vision correction and comfort with a "piggyback" lens combination, in which RGP lenses are worn over soft lenses, both providing a degree of vision correction. One form of piggyback lens makes use of a soft lens with a countersunk central area to accept the rigid lens. Fitting a piggyback lens combination requires experience on the part of the lens fitter, and tolerance on the part of the person with keratoconus.
===== MeSH D08.811.682.664 – oxidoreductases acting on ch-nh2 group donors ===== MeSH D08.811.682.664.249 – amine oxidase (copper-containing) MeSH D08.811.682.664.500 – amino acid oxidoreductases MeSH D08.811.682.664.500.062 – alanine dehydrogenase MeSH D08.811.682.664.500.125 – d-amino-acid oxidase MeSH D08.811.682.664.500.261 – d-aspartate oxidase MeSH D08.811.682.664.500.398 – glutamate dehydrogenase MeSH D08.811.682.664.500.410 – glutamate dehydrogenase (nadp+) MeSH D08.811.682.664.500.470 – glutamate synthase (NADPH) MeSH D08.811.682.664.500.484 – glutamate synthase (NADH) MeSH D08.811.682.664.500.498 – glycine decarboxylase complex MeSH D08.811.682.664.500.498.500 – glycine dehydrogenase (decarboxylating) MeSH D08.811.682.664.500.526 – glycine dehydrogenase MeSH D08.811.682.664.500.677 – l-amino acid oxidase MeSH D08.811.682.664.500.724 – leucine dehydrogenase MeSH D08.811.682.664.500.772 – nitric oxide synthase MeSH D08.811.682.664.500.772.249 – nitric oxide synthase type i MeSH D08.811.682.664.500.772.500 – nitric oxide synthase type ii MeSH D08.811.682.664.500.772.750 – nitric oxide synthase type iii MeSH D08.811.682.664.500.810 – proline oxidase MeSH D08.811.682.664.500.848 – protein-lysine 6-oxidase MeSH D08.811.682.664.500.924 – valine dehydrogenase (NADP+) MeSH D08.811.682.664.750 – monoamine oxidase MeSH D08.811.682.664.750.100 – benzylamine oxidase
=== Daniel Van Deventer === Daniel Van Deventer (Alex Akpobome), nicknamed “DVD,” is a Pierpoint trader transferred from New York to London during plans to consolidate the two offices. A former protégé of Eric Tao, DVD’s rapid rise places him in direct competition with Eric, ultimately contributing to Eric’s demotion after the loss of Felim Bichan as a client. DVD assumes Eric’s responsibilities as CPS MD and begins a sexual relationship with Harper, encouraging her to consider relocating to New York as the London office faces closure. He later suspends Harper after secretly listening in on a call in which she helps Jesse Bloom unload positions at Pierpoint’s expense. DVD grows disillusioned with Pierpoint after being instructed by Adler to ignore Nicole Craig’s sexual assault of Venetia Berens, and sympathizes with Harper upon learning she was also assaulted by Nicole. He agrees to leave the firm with Harper, Eric, and Rishi, but is ultimately betrayed when Harper and Eric strike a deal with Adler to preserve a reduced London operation by branding DVD and Rishi as disloyal. DVD is fired along with much of the London office, discovering his dismissal only when his security badge stops working.
In 2006, sales of Guinness in Ireland and the United Kingdom declined 7 percent. Despite this, Guinness still accounts for more than a quarter of all beer sold in Ireland. By 2015, sales were on the rise in Ireland but flat globally. By 2023, Guinness had grown to become the most popular draught beer in the United Kingdom, with about 11% of all sales. Guinness began retailing in India in 2007. Guinness has a significant share of the African beer market, where it has been sold since 1827. About 40 percent of worldwide total Guinness volume is brewed and sold in Africa, with Foreign Extra Stout the most popular variant. Three of the five Guinness-owned breweries worldwide are located in Africa. The beer is brewed under licence internationally in several countries, including Nigeria, the Bahamas, Canada, Cameroon, Kenya, Uganda, South Korea, Namibia, and Indonesia. In 2017, Guinness teamed up with AB InBev to distribute Guinness in mainland China. China is the single biggest worldwide alcohol market, especially for imported craft beers like Guinness. In 2025, AB InBev started brewing Guinness under licence in China. Initial reception was not favourable, with one publican reportedly stating that the "feedback from everyone is that it tastes like cigarettes or an ashtray. The taste is not the same at all and the aftertaste is terrible". In November 2025, Diego announced a "double-digit" decline in sales in China. The United Kingdom is the only sovereign state to consume more Guinness than Ireland.
Sources: en.wikipedia.org
Adding to the speculation, it was revealed that Trump had made an hours-long visit to Walter Reed National Military Medical Center, his third visit within a year, where doctors administered what Trump says was his fourth Montreal Cognitive Assessment test. White House spokesperson Davis Ingle refuted concerns about Trump's health, stating the president had completed multiple engagements with open press slots for the end of the week, and labeled the concerns as "left-wing conspiracies". When questioned about his opinion of the president receiving four medical checkups since the beginning of his second term, Mehmet Oz told reporters that Trump was in perfect health and kept returning for checkups as he likes the results and aces the tests every visit. On June 3, during a House Foreign Affairs Committee Representative Ted Lieu (D-CA) questioned Secretary of State Marco Rubio over Trump's apparent sleeping in multiple public appearances such as Cabinet meetings. Rubio refuted the idea that Trump was sleeping, claiming that instead Trump does not sleep, and when presented with a video of Trump, appearing to sleep next to Rubio speaking about the Iran war Rubio doubled down claiming that Trump was not sleeping. Lieu expressed concern about how foreign leaders perceive Trump and the United States, and presented a foreign news segment video in which they mocked Trump "fighting sleep" during a Memorial Day ceremony. Trump also appeared to fall asleep at Game 3 of the 2026 NBA finals at Madison Square Garden.
In many organisms including Xenopus and Drosophila, the midblastula transition usually occurs after a particular number of cell divisions for a given species, and is defined by the ending of the synchronous cell division cycles of the early blastula development, and the lengthening of the cell cycles by the addition of the G1 and G2 phases. Prior to this transition, cleavage occurs with only the synthesis and mitosis phases of the cell cycle. The addition of the two growth phases into the cell cycle allows for the cells to increase in size, as up to this point the blastomeres undergo reductive divisions in which the overall size of the embryo does not increase, but more cells are created. This transition begins the growth in size of the organism. The mid-blastula transition is also characterized by a marked increase in transcription of new, non-maternal mRNA transcribed from the genome of the organism. Large amounts of the maternal mRNA are destroyed at this point, either by proteins such as SMAUG in Drosophila or by microRNA. These two processes shift the control of the embryo from the maternal mRNA to the nuclei.
== Definition of stability, and naturally occurring nuclides == Most naturally occurring nuclides are stable (about 251; see list at the end of this article), and about 35 more (total of 286) are known to be radioactive with long enough half-lives (also known) to occur primordially. If the half-life of a nuclide is comparable to, or greater than, the Earth's age (4.5 billion years), a significant amount will have survived since the formation of the Solar System, and then is said to be primordial. It will then contribute in that way to the natural isotopic composition of a chemical element. Primordial radioisotopes are easily detected with half-lives as short as 700 million years (e.g., 235U). Shorter-lived nuclides have not yet been detected undisputedly in nature except when recently produced, such as decay products or cosmic ray spallation. Many naturally occurring radioisotopes (another 53 or so, for a total of about 339) exhibit still shorter half-lives than 700 million years, but they are made freshly, as daughter products of decay processes of primordial nuclides (for example, radium isotopes from uranium decay), or from ongoing energetic reactions, such as cosmogenic nuclides produced by present bombardment of Earth by cosmic rays (for example, 14C made from nitrogen). Some isotopes that are classed as stable (i.e. no radioactivity has been observed for them) are predicted to have extremely long half-lives (sometimes 1018 years or more).
== Adverse effects == Bexagliflozin may cause ketoacidosis, a serious, potentially life-threatening complication that occurs when the body produces high levels of acids in the blood. Bexagliflozin may also cause serious side effects such as an increased incidence for surgery to remove parts of the legs or feet, decreases in blood pressure due to excessive loss of water and sodium from the body, serious infections in the genital region (Fournier's gangrene), very low blood sugar levels when used in combination with insulin or medications that increase insulin in the body, and serious urinary tract infections.
In August 2008, Svante Cornell, Johanna Popjanevski and Niklas Nilsson from the Swedish Institute for Security and Development Policy commented that preceding the war, "Moscow's increasingly blatant provocations against Georgia led to a growing fear in the analytic community that it was seeking a military confrontation," adding "Russia had been meticulously preparing an invasion of Georgia through the substantial massing and preparation of forces in the country's immediate vicinity." The paper pointed out that its assertions were "initial conclusions," and because of "the recent nature of the events, however, it is possible that some information reflected here will need correction as more solid evidence emerges."
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.